Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone for Skeletal Muscle Dysfunction in RA
NCT02535832Phase 1Completed
- Sponsor
- The Ohio State University
- Start
- Sep 2015
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in insulin resistance (IR) comparing Pioglitazone with Placebo (2 arms). Primary endpoints: Insulin sensitivity, Skeletal muscle strength in the quadriceps muscle at 12 weeks and 1 more. Started Sep 2015; status: completed.
02
Drugs
pioglitazone
03
Conditions
insulin resistance (IR)
Beyond the preview
Go deeper on NCT02535832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02535832.